Xiaoming Zhang - 12 Aug 2021 Form 3 Insider Report for Vincerx Pharma, Inc. (VINC)

Role
Chief Technology Officer
Signature
/s/ Xiaoming Zhang
Issuer symbol
VINC
Transactions as of
12 Aug 2021
Net transactions value
$0
Form type
3
Filing time
16 Aug 2021, 16:05:24 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VINC Stock Option (right to buy) 12 Aug 2021 Common Stock 150,000 $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests over two years, with 1/3 of the shares vesting on December 23, 2020, and 1/36th of the shares vesting monthly thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney